Treatment of steroid-resistant rejections with ATG and/or plasma filtration improves graft survival rates after cadaveric kidney transplantation.
D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001769:Blood; D002102:Cadaver; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D011446:Prospective Studies; D013601:T-Lymphocytes / Q000276:immunology*; D014462:Ultrafiltration
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents